Resolution of dyskinesia and the "on-off" phenomenon in thyrotoxic patients with Parkinson's disease after antithyroid treatment.
作者信息
Caradoc-Davies T H
出版信息
Br Med J (Clin Res Ed). 1986 Jul 5;293(6538):38-9. doi: 10.1136/bmj.293.6538.38.
Abstract
摘要
相似文献
1
Resolution of dyskinesia and the "on-off" phenomenon in thyrotoxic patients with Parkinson's disease after antithyroid treatment.抗甲状腺治疗后帕金森病合并甲状腺毒症患者运动障碍及“开-关”现象的缓解
Br Med J (Clin Res Ed). 1986 Jul 5;293(6538):38-9. doi: 10.1136/bmj.293.6538.38.
2
Hyperthyroidism "masked" the levodopa response in newly diagnosed Parkinson's disease patients.甲状腺功能亢进症“掩盖”了新诊断帕金森病患者对左旋多巴的反应。
Parkinsonism Relat Disord. 2010 Dec;16(10):691-2. doi: 10.1016/j.parkreldis.2010.07.009. Epub 2010 Aug 21.
3
Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.帕金森病中左旋多巴诱导的运动障碍和开-关现象发展的预测因素。
Mov Disord. 2013 Jul;28(8):1064-71. doi: 10.1002/mds.25364. Epub 2013 Apr 29.
4
Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia.在引入美金刚治疗帕金森病痴呆后，左旋多巴诱发的异动症和开关现象出现意外改善。
J Am Geriatr Soc. 2013 Jan;61(1):170-2. doi: 10.1111/jgs.12058.
5
[Two cases of Parkinson's disease with diphasic dyskinesia, seen during levodopa treatment (author's transl)].
Rinsho Shinkeigaku. 1982 Mar;22(3):209-15.
6
Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia.帕金森病的严重程度是峰值剂量运动障碍的一个风险因素。
J Neurol Neurosurg Psychiatry. 1990 Mar;53(3):224-6. doi: 10.1136/jnnp.53.3.224.
7
Blink reflex in Parkinson's disease with levodopa-induced dyskinesia.帕金森病伴左旋多巴诱导的异动症的瞬目反射
Funct Neurol. 1989 Jul-Sep;4(3):257-61.
8
Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial.托扎丹特（SYN115）治疗伴有左旋多巴运动波动的帕金森病患者的疗效：一项 2b 期、双盲、随机试验。
Lancet Neurol. 2014 Aug;13(8):767-76. doi: 10.1016/S1474-4422(14)70148-6. Epub 2014 Jul 6.
9
AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.AFQ056 在伴有左旋多巴诱导运动障碍的帕金森病患者中的 13 周、随机、剂量发现研究。
Mov Disord. 2013 Nov;28(13):1838-46. doi: 10.1002/mds.25561. Epub 2013 Jul 12.
10
Conjugate eye deviations as dyskinesias induced by levodopa in Parkinson's disease.帕金森病中左旋多巴诱发的异动症所致的共轭性眼球偏斜
Mov Disord. 1998 Jul;13(4):731-4. doi: 10.1002/mds.870130421.
引用本文的文献
1
Thyroid Disorders and Movement Disorders-A Systematic Review.甲状腺疾病与运动障碍——一项系统评价
Mov Disord Clin Pract. 2023 Feb 3;10(3):360-368. doi: 10.1002/mdc3.13656. eCollection 2023 Mar.
2
Thyroid hormone level is associated with motor symptoms in de novo Parkinson's disease.甲状腺激素水平与新发帕金森病的运动症状相关。
J Neurol. 2015 Jul;262(7):1762-8. doi: 10.1007/s00415-015-7780-x. Epub 2015 May 19.
3
Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats.左旋多巴诱导的运动障碍与半帕金森病大鼠背侧纹状体中促甲状腺素释放激素的增加有关。
PLoS One. 2010 Nov 10;5(11):e13861. doi: 10.1371/journal.pone.0013861.
4
Graves' disease presenting as hemiparkinsonism.以偏侧帕金森综合征为表现的格雷夫斯病
J Endocrinol Invest. 2001 Mar;24(3):188-9. doi: 10.1007/BF03343841.
5
Ultrasensitive TSH assay and anti-parkinsonian treatment with levodopa.超敏促甲状腺激素检测与左旋多巴抗帕金森病治疗
J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1210-1. doi: 10.1136/jnnp.55.12.1210-a.
本文引用的文献
1
Depression and Parkinson's disease.
Adv Neurol. 1984;40:241-50.
2
Brief assessment of the mental state in geriatric domiciliary practice. The usefulness of the mental status questionnaire.老年家庭医疗中精神状态的简要评估。精神状态问卷的实用性。
Age Ageing. 1973 May;2(2):92-101. doi: 10.1093/ageing/2.2.92.
3
L-DOPA suppression of thyrotropin-releasing hormone response in man.
J Clin Endocrinol Metab. 1972 Jul;35(1):182-5. doi: 10.1210/jcem-35-1-182.
4
Parkinsonism and hyperthyroidism.
Eur Neurol. 1974;12(1):20-7. doi: 10.1159/000114600.
5
Interaction of thyrotropin-releasing hormone and dopamine on the release of prolactin from the rat anterior pituitary in vitro.促甲状腺激素释放激素与多巴胺对大鼠垂体前叶催乳素体外释放的相互作用。
Endocrinology. 1974 Oct;95(4):1189-92. doi: 10.1210/endo-95-4-1189.
6
Hyperthyroidism in patients over the age of 60 years. Clinical features in 85 patients.
Medicine (Baltimore). 1974 May;53(3):161-81. doi: 10.1097/00005792-197405000-00001.
7
8
Use of thyrotropin-releasing hormone in clinical medicine.促甲状腺激素释放激素在临床医学中的应用。
Med Clin North Am. 1978 Mar;62(2):313-25. doi: 10.1016/s0025-7125(16)31808-9.
9
"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy.
Lancet. 1976 Feb 7;1(7954):292-6. doi: 10.1016/s0140-6736(76)91416-1.
Zotero 插件